Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7932)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2013 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu XX, Chen YT, Feng B, Mao XB, Yu B, Chu XY. Expression and clinical significance of CD73 and hypoxia-inducible factor-1α in gastric carcinoma. World J Gastroenterol 2013; 19(12): 1912-1918 [PMID: 23569336 DOI: 10.3748/wjg.v19.i12.1912] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i12/1912.htm |
| Number | Citing Articles |
| 1 |
Ana Paula Santin Bertoni, Paula Andreghetto Bracco, Rafael Paschoal de Campos, Bruna Schwengber Lutz, Beatriz Maria Assis-Brasil, Erika Laurini de Souza Meyer, Jenifer Saffi, Elizandra Braganhol, Tania Weber Furlanetto, Márcia Rosângela Wink. Activity of ecto-5′-nucleotidase (NT5E/CD73) is increased in papillary thyroid carcinoma and its expression is associated with metastatic lymph nodes. Molecular and Cellular Endocrinology 2019; 479: 54 doi: 10.1016/j.mce.2018.08.013
|
| 2 |
Zhijun Xu, Chuncai Gu, Xingxing Yao, Weihong Guo, Huanan Wang, Tian Lin, Fengping Li, Da Chen, Jianhua Wu, Gengtai Ye, Liying Zhao, Yanfeng Hu, Jiang Yu, Jiaolong Shi, Guoxin Li, Hao Liu. CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer. Cell Death & Disease 2020; 11(3) doi: 10.1038/s41419-020-2403-6
|
| 3 |
Giulia Bertolini, Mara Compagno, Dimas Carolina Belisario, Cristiano Bracci, Tullio Genova, Federico Mussano, Massimo Vitale, Alberto Horenstein, Fabio Malavasi, Riccardo Ferracini, Ilaria Roato. CD73/Adenosine Pathway Involvement in the Interaction of Non-Small Cell Lung Cancer Stem Cells and Bone Cells in the Pre-Metastatic Niche. International Journal of Molecular Sciences 2022; 23(9): 5126 doi: 10.3390/ijms23095126
|
| 4 |
Mizuki Izawa, Nobuyuki Tanaka, Tetsushi Murakami, Tadatsugu Anno, Yu Teranishi, Kimiharu Takamatsu, Shuji Mikami, Kazuhiro Kakimi, Takeshi Imamura, Kazuhiro Matsumoto, Mototsugu Oya. Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer. Laboratory Investigation 2023; 103(4): 100040 doi: 10.1016/j.labinv.2022.100040
|
| 5 |
Young Mun Jeong, Haejin Cho, Tae-Min Kim, Yourha Kim, Sora Jeon, Andrey Bychkov, Chan Kwon Jung. CD73 Overexpression Promotes Progression and Recurrence of Papillary Thyroid Carcinoma. Cancers 2020; 12(10): 3042 doi: 10.3390/cancers12103042
|
| 6 |
Dipti Vijayan, Mark J. Smyth, Michele W. L. Teng. Oncoimmunology. 2018; : 115 doi: 10.1007/978-3-319-62431-0_7
|
| 7 |
Robert D. Leone, Leisha A. Emens. Targeting adenosine for cancer immunotherapy. Journal for ImmunoTherapy of Cancer 2018; 6(1) doi: 10.1186/s40425-018-0360-8
|
| 8 |
Qiangda Chen, Ning Pu, Hanlin Yin, Jicheng Zhang, Guochao Zhao, Wenhui Lou, Wenchuan Wu. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer. Journal of Cellular and Molecular Medicine 2020; 24(15): 8674 doi: 10.1111/jcmm.15500
|
| 9 |
Martin Turcotte, Kathleen Spring, Sandra Pommey, Guillaume Chouinard, Isabelle Cousineau, Joshy George, Gregory M. Chen, Deena M.A. Gendoo, Benjamin Haibe-Kains, Thomas Karn, Kurosh Rahimi, Cécile Le Page, Diane Provencher, Anne-Marie Mes-Masson, John Stagg. CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer. Cancer Research 2015; 75(21): 4494 doi: 10.1158/0008-5472.CAN-14-3569
|
| 10 |
Alexandra Borodovsky, Christine M Barbon, Yanjun Wang, Minwei Ye, Laura Prickett, Dinesh Chandra, Joseph Shaw, Nanhua Deng, Kris Sachsenmeier, James D Clarke, Bolan Linghu, Giles A Brown, James Brown, Miles Congreve, Robert KY Cheng, Andrew S Dore, Edward Hurrell, Wenlin Shao, Richard Woessner, Corinne Reimer, Lisa Drew, Stephen Fawell, Alwin G Schuller, Deanna A Mele. Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity. Journal for ImmunoTherapy of Cancer 2020; 8(2): e000417 doi: 10.1136/jitc-2019-000417
|
| 11 |
Ghasem Ghalamfarsa, Mohammad Hossein Kazemi, Sahar Raoofi Mohseni, Ali Masjedi, Mohammad Hojjat-Farsangi, Gholamreza Azizi, Mehdi Yousefi, Farhad Jadidi-Niaragh. CD73 as a potential opportunity for cancer immunotherapy. Expert Opinion on Therapeutic Targets 2019; 23(2): 127 doi: 10.1080/14728222.2019.1559829
|
| 12 |
Ashish Kumar Mishra, Siddharth Kumar Singh, Sruthilaya Dayanandan, Smaran Banerjee, Soumyadeep Chakraborty, Akshita Baiju Gopal, Supriya Samal, Indrajit Poirah, Debashish Chakraborty, Asima Bhattacharyya. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster. Cytokine 2022; 156: 155917 doi: 10.1016/j.cyto.2022.155917
|
| 13 |
Ali Safarzadeh, Mohsen Alizadeh, Fatemeh Beyranvand, Reza Falavand Jozaaee, Khalil Hajiasgharzadeh, Amir Baghbanzadeh, Afshin Derakhshani, Antonella Argentiero, Behzad Baradaran, Nicola Silvestris. Varied functions of immune checkpoints during cancer metastasis. Cancer Immunology, Immunotherapy 2021; 70(3): 569 doi: 10.1007/s00262-020-02717-2
|
| 14 |
Jianjie Zhu, Yuanyuan Zeng, Wei Li, Hualong Qin, Zhe Lei, Dan Shen, Dongmei Gu, Jian-an Huang, Zeyi Liu. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0591-1
|
| 15 |
Sifeng Hu, Fanmei Meng, Xiankun Yin, Changling Cao, Guangyong Zhang. NT5E is associated with unfavorable prognosis and regulates cell proliferation and motility in gastric cancer. Bioscience Reports 2019; 39(5) doi: 10.1042/BSR20190101
|
| 16 |
Yongjun Sun, Jie Ma, Junkai Lin, Dawei Sun, Ping Song, Lujing Shi, Hongtao Li, Ruijie Wang, Ziwen Wang, Shijun Liu. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis. Anti-Cancer Drugs 2021; 32(9): 950 doi: 10.1097/CAD.0000000000001087
|
| 17 |
Eric Tu, Kelly McGlinchey, Jixin Wang, Philip Martin, Steven L.K. Ching, Nicolas Floc’h, James Kurasawa, Jacqueline H. Starrett, Yelena Lazdun, Leslie Wetzel, Barrett Nuttall, Felicia S.L. Ng, Karen T. Coffman, Paul D. Smith, Katerina Politi, Zachary A. Cooper, Katie Streicher. Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC. JCI Insight 2022; 7(3) doi: 10.1172/jci.insight.142843
|
| 18 |
Akil Hammami, David Allard, Bertrand Allard, John Stagg. Targeting the adenosine pathway for cancer immunotherapy. Seminars in Immunology 2019; 42: 101304 doi: 10.1016/j.smim.2019.101304
|
| 19 |
Erik Wennerberg, Claire Lhuillier, Claire Vanpouille-Box, Karsten A. Pilones, Elena García-Martínez, Nils-Petter Rudqvist, Silvia C. Formenti, Sandra Demaria. Barriers to Radiation-Induced In Situ Tumor Vaccination. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00229
|
| 20 |
Rui Pinto-Cardoso, Catarina Bessa-Andrês, Paulo Correia-de-Sá, José Bernardo Noronha-Matos. Could hypoxia rehabilitate the osteochondral diseased interface? Lessons from the interplay of hypoxia and purinergic signals elsewhere. Biochemical Pharmacology 2023; 214: 115646 doi: 10.1016/j.bcp.2023.115646
|
| 21 |
Katherine C. Kurnit, Ashley Draisey, Rebecca C. Kazen, Christine Chung, Luan H. Phan, Jerry B. Harvey, Jiping Feng, SuSu Xie, Russell R. Broaddus, Jessica L. Bowser. Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer. Cancer Letters 2021; 505: 75 doi: 10.1016/j.canlet.2021.01.030
|
| 22 |
Andrea M. Chambers, Sandro Matosevic. Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors. Frontiers in Molecular Biosciences 2019; 6 doi: 10.3389/fmolb.2019.00060
|
| 23 |
Farnaz Hajizadeh, Ali Masjedi, Sima Heydarzedeh Asl, Fariba Karoon Kiani, Makwan Peydaveisi, Ghasem Ghalamfarsa, Farhad Jadidi-Niaragh, Andrey Sevbitov. Adenosine and adenosine receptors in colorectal cancer. International Immunopharmacology 2020; 87: 106853 doi: 10.1016/j.intimp.2020.106853
|
| 24 |
Rosario García-Rocha, Alberto Monroy-García, Jorge Hernández-Montes, Benny Weiss-Steider, Vianey Gutiérrez-Serrano, María del Carmen Fuentes-Castañeda, Luis Roberto Ávila-Ibarra, Christian Azucena Don-López, Daniela Berenice Torres-Pineda, María de Lourdes Mora-García. Cervical cancer cells produce TGF-β1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-β1. Cytokine 2019; 118: 71 doi: 10.1016/j.cyto.2018.09.018
|
| 25 |
松 黄. CD73: A New Target for Cancer Immunotherapy. Pharmacy Information 2022; 11(04): 259 doi: 10.12677/PI.2022.114034
|
| 26 |
Shilpak Chatterjee, Krishnamurthy Thyagarajan, Pravin Kesarwani, Jin H. Song, Myroslawa Soloshchenko, Jianing Fu, Stefanie R. Bailey, Chenthamarkshan Vasu, Andrew S. Kraft, Chrystal M. Paulos, Xue-Zhong Yu, Shikhar Mehrotra. Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors. Cancer Research 2014; 74(21): 6048 doi: 10.1158/0008-5472.CAN-14-1450
|
| 27 |
Jiao Wang, Sandro Matosevic. Adenosinergic signaling as a target for natural killer cell immunotherapy. Journal of Molecular Medicine 2018; 96(9): 903 doi: 10.1007/s00109-018-1679-9
|
| 28 |
Linsen Shi, Lin Yang, Zhaoyin Wu, Wei Xu, Jun Song, Wenxian Guan. Adenosine signaling: Next checkpoint for gastric cancer immunotherapy?. International Immunopharmacology 2018; 63: 58 doi: 10.1016/j.intimp.2018.07.023
|
| 29 |
Jianan Zhu, Guangmin Song, Xiaobo Zhou, Ting-Li Han, Xinyang Yu, Hao Chen, Toby Mansell, Boris Novakovic, Philip N. Baker, Richard D. Cannon, Richard Saffery, Chang Chen, Hua Zhang. CD39/CD73 Dysregulation of Adenosine Metabolism Increases Decidual Natural Killer Cell Cytotoxicity: Implications in Unexplained Recurrent Spontaneous Abortion. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.813218
|
| 30 |
Roberta Turiello, Aldo Pinto, Silvana Morello. CD73: A Promising Biomarker in Cancer Patients. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.609931
|
| 31 |
Xu Yang, Shimin Pei, Huanan Wang, Yipeng Jin, Fang Yu, Bin Zhou, Hong Zhang, Di Zhang, Degui Lin. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3250-4
|
| 32 |
Elham Baghbani, Saeed Noorolyai, Dariush Shanehbandi, Ahad Mokhtarzadeh, Leili Aghebati-Maleki, Vahid Khaze Shahgoli, Oronzo Brunetti, Shima Rahmani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nicola Silvestris, Behzad Baradaran. Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints. Life Sciences 2021; 282: 119826 doi: 10.1016/j.lfs.2021.119826
|
| 33 |
Miles Congreve, Giles A. Brown, Alexandra Borodovsky, Michelle L. Lamb. Targeting adenosine A2A receptor antagonism for treatment of cancer. Expert Opinion on Drug Discovery 2018; 13(11): 997 doi: 10.1080/17460441.2018.1534825
|
| 34 |
David Allard, Bertrand Allard, Pierre-Olivier Gaudreau, Pavel Chrobak, John Stagg. CD73–adenosine: a next-generation target in immuno-oncology. Immunotherapy 2016; 8(2): 145 doi: 10.2217/imt.15.106
|
| 35 |
Arghya Ray, Yan Song, Ting Du, Leutz Buon, Yu-Tzu Tai, Dharminder Chauhan, Kenneth C. Anderson. Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma. Blood Cancer Journal 2022; 12(4) doi: 10.1038/s41408-022-00635-3
|
| 36 |
Shunsuke Kondo, Satoru Iwasa, Takafumi Koyama, Tomoko Fujita, Ko Sugibayashi, Kosho Murayama, Noboru Yamamoto. Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study. International Journal of Clinical Oncology 2022; 27(12): 1795 doi: 10.1007/s10147-022-02242-5
|
| 37 |
Juliana Hofstätter Azambuja, Nils Ludwig, Elizandra Braganhol, Theresa L. Whiteside. Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity. International Journal of Molecular Sciences 2019; 20(22): 5698 doi: 10.3390/ijms20225698
|
| 38 |
Minghao Xie, Huabo Qin, Qianxin Luo, Qunsheng Huang, Xiaosheng He, Zihuan Yang, Ping Lan, Lei Lian. MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3291-8
|
| 39 |
Luca Antonioli, Gennady G. Yegutkin, Pál Pacher, Corrado Blandizzi, György Haskó. Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities. Trends in Cancer 2016; 2(2): 95 doi: 10.1016/j.trecan.2016.01.003
|
| 40 |
Niklas Bach, Riekje Winzer, Eva Tolosa, Walter Fiedler, Franziska Brauneck. The Clinical Significance of CD73 in Cancer. International Journal of Molecular Sciences 2023; 24(14): 11759 doi: 10.3390/ijms241411759
|
| 41 |
Tao Jiang, Xiaofeng Xu, Meng Qiao, Xuefei Li, Chao Zhao, Fei Zhou, Guanghui Gao, Fengying Wu, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Changyun Zhai, Caicun Zhou. Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4073-7
|
| 42 |
Kohei Ono, Eisuke Shiozawa, Nobuyuki Ohike, Tomonori Fujii, Hideki Shibata, Tetsuya Kitajima, Koichiro Fujimasa, Naoko Okamoto, Yukiko Kawaguchi, Tasuku Nagumo, Sakiko Tazawa, Mayumi Homma, Toshiko Yamochi‑Onizuka, Tomoko Norose, Hitoshi Yoshida, Masahiko Murakami, Gensyu Tate, Masafumi Takimoto. Immunohistochemical CD73 expression status in gastrointestinal neuroendocrine neoplasms: A retrospective study of 136�patients. Oncology Letters 2017; doi: 10.3892/ol.2017.7569
|
| 43 |
Farnaz Hajizadeh, Isobel Okoye, Maryam Esmaily, Mitra Ghasemi Chaleshtari, Ali Masjedi, Gholamreza Azizi, Mahzad Irandoust, Ghasem Ghalamfarsa, Farhad Jadidi-Niaragh. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sciences 2019; 237: 116952 doi: 10.1016/j.lfs.2019.116952
|
| 44 |
Mariaelena Capone, Federica Fratangelo, Diana Giannarelli, Claudia Sorrentino, Roberta Turiello, Serena Zanotta, Domenico Galati, Gabriele Madonna, Marilena Tuffanelli, Luigi Scarpato, Antonio M. Grimaldi, Assunta Esposito, Rosa Azzaro, Antonio Pinto, Ernesta Cavalcanti, Aldo Pinto, Silvana Morello, Paolo A. Ascierto. Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02285-0
|
| 45 |
Sandro Matosevic. Systemic Drug Delivery Strategies. 2022; : 63 doi: 10.1016/B978-0-323-85781-9.00003-8
|
| 46 |
Rui Yang, Samah Elsaadi, Kristine Misund, Pegah Abdollahi, Esten Nymoen Vandsemb, Siv Helen Moen, Anna Kusnierczyk, Geir Slupphaug, Therese Standal, Anders Waage, Tobias S Slørdahl, Torstein Baade Rø, Even Rustad, Anders Sundan, Carl Hay, Zachary Cooper, Alwin G Schuller, Richard Woessner, Alexandra Borodovsky, Eline Menu, Magne Børset, Anne Marit Sponaas. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. Journal for ImmunoTherapy of Cancer 2020; 8(1): e000610 doi: 10.1136/jitc-2020-000610
|
| 47 |
Rong Wang, Yingying Zhang, Xia Lin, Yalin Gao, Ying Zhu. Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review. Oncotarget 2017; 8(34): 57327 doi: 10.18632/oncotarget.16905
|
| 48 |
M. Aoki, K. Koga, M. Miyazaki, M. Hamasaki, N. Koshikawa, M. Oyama, H. Kozuka-Hata, M. Seiki, B. P. Toole, K. Nabeshima. CD73 complexes with emmprin to regulate MMP-2 production from co-cultured sarcoma cells and fibroblasts. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6127-x
|
| 49 |
Jun Zhao, Luisa M. Solis Soto, Hua Wang, Matthew H. Katz, Laura R. Prakash, Michael Kim, Ching-Wei D. Tzeng, Jeffrey E. Lee, Robert A. Wolff, Yanqing Huang, Ignacio I. Wistuba, Anirban Maitra, Huamin Wang. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology 2021; 21(5): 942 doi: 10.1016/j.pan.2021.03.018
|
| 50 |
Jerry B. Harvey, Luan H. Phan, Oscar E. Villarreal, Jessica L. Bowser. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00508
|
| 51 |
Dipti Vijayan, Arabella Young, Michele W.L. Teng, Mark J. Smyth. Targeting immunosuppressive adenosine in cancer. Nature Reviews Cancer 2017; 17(12): 709 doi: 10.1038/nrc.2017.86
|
| 52 |
Gang Wang, Shan Fu, Dechuan Li, Yinbo Chen. Expression and clinical significance of serum NT5E protein in patients with colorectal cancer. Cancer Biomarkers 2019; 24(4): 461 doi: 10.3233/CBM-182207
|
| 53 |
Kyle Lupo, Sandro Matosevic. Successes and Challenges of NK Immunotherapy. 2021; : 349 doi: 10.1016/B978-0-12-824375-6.00015-1
|
| 54 |
Vitória Brum da Silva Nunes, Camila Kehl Dias, Marco Antônio De Bastiani, Mariela Granero Farias, Fabiane Spagnol, Ana Paula Alegretti, Liane Esteves Daudt, Mariana Bohns Michalowski, Ana Maria Oliveira Battastini, Alessandra Aparecida Paz, Fabrício Figueiró. NT5E gene and CD38 protein as potential prognostic biomarkers for childhood B-acute lymphoblastic leukemia. Purinergic Signalling 2022; 18(2): 211 doi: 10.1007/s11302-022-09841-x
|
| 55 |
Marko Salmi, Sirpa Jalkanen. Ectoenzymes in leukocyte migration and their therapeutic potential. Seminars in Immunopathology 2014; 36(2): 163 doi: 10.1007/s00281-014-0417-9
|
| 56 |
Bo Wang, Dong Wang, ZhiZhong Zhu, Wei Wang, XueBin Zhang, Fan Tang, Yu Zhou, HongGuang Wang, MengYuan Liu, Xin Yao, XiaoLing Yan. The role of extracellular-5′-nucleotidase/CD73 in glioma peritumoural brain edema. Neurological Sciences 2016; 37(4): 603 doi: 10.1007/s10072-016-2510-4
|
| 57 |
Fabio Morandi, Barbara Morandi, Alberto L. Horenstein, Antonella Chillemi, Valeria Quarona, Gianluca Zaccarello, Paolo Carrega, Guido Ferlazzo, Maria Cristina Mingari, Lorenzo Moretta, Vito Pistoia, Fabio Malavasi. A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation. Oncotarget 2015; 6(28): 25602 doi: 10.18632/oncotarget.4693
|
| 58 |
ZHEN-HU REN, YONG-XIANG YUAN, TONG JI, CHEN-PING ZHANG. CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma. Oncology Letters 2016; 12(1): 556 doi: 10.3892/ol.2016.4652
|
| 59 |
Han-Yuan Liu, Fu-Hui Wang, Jian-Ming Liang, Yuan-Yuan Xiang, Shu-Hao Liu, Shi-Wei Zhang, Cheng-Ming Zhu, Yu-Long He, Chang-Hua Zhang. Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(7): 2743 doi: 10.1007/s00432-022-04124-9
|
| 60 |
Yuta Yamada, Ken‐ichi Takayama, Tetsuya Fujimura, Daisaku Ashikari, Daisuke Obinata, Satoru Takahashi, Kazuhiro Ikeda, Shigenori Kakutani, Tomohiko Urano, Hiroshi Fukuhara, Yukio Homma, Satoshi Inoue. A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor. Cancer Science 2017; 108(1): 32 doi: 10.1111/cas.13105
|
| 61 |
Laura Cartularo, Freda Laulicht, Hong Sun, Thomas Kluz, Jonathan H. Freedman, Max Costa. Gene expression and pathway analysis of human hepatocellular carcinoma cells treated with cadmium. Toxicology and Applied Pharmacology 2015; 288(3): 399 doi: 10.1016/j.taap.2015.08.011
|
| 62 |
Xiaohui Du, Jared Moore, Brian R. Blank, John Eksterowicz, Dena Sutimantanapi, Natalie Yuen, Todd Metzger, Brenda Chan, Tom Huang, Xi Chen, Yuping Chen, Frank Duong, Wayne Kong, Jae H. Chang, Jessica Sun, Tatiana Zavorotinskaya, Qiuping Ye, Melissa R. Junttila, Chudi Ndubaku, Lori S. Friedman, Valeria R. Fantin, Daqing Sun. Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production. Journal of Medicinal Chemistry 2020; 63(18): 10433 doi: 10.1021/acs.jmedchem.0c01086
|
| 63 |
Jieyao Li, Liping Wang, Xinfeng Chen, Lifeng Li, Yu Li, Yu Ping, Lan Huang, Dongli Yue, Zhen Zhang, Fei Wang, Feng Li, Li Yang, Jianmin Huang, Shuangning Yang, Hong Li, Xuan Zhao, Wenjie Dong, Yan Yan, Song Zhao, Bo Huang, Bin Zhang, Yi Zhang. CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer. OncoImmunology 2017; 6(6) doi: 10.1080/2162402X.2017.1320011
|
| 64 |
David Allard, Pavel Chrobak, Bertrand Allard, Nouredin Messaoudi, John Stagg. Targeting the CD73-adenosine axis in immuno-oncology. Immunology Letters 2019; 205: 31 doi: 10.1016/j.imlet.2018.05.001
|
| 65 |
Hidenobu Ishii, Koichi Azuma, Akihiko Kawahara, Takashi Kinoshita, Norikazu Matsuo, Yoshiko Naito, Takaaki Tokito, Kazuhiko Yamada, Jun Akiba, Tomoaki Hoshino. Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC. Thoracic Cancer 2020; 11(4): 950 doi: 10.1111/1759-7714.13346
|
| 66 |
Hitomi Sudo, Atsushi B. Tsuji, Aya Sugyo, Gene Kurosawa, Yoshikazu Kurosawa, David Alexander, Hiroyuki Tsuda, Tsuneo Saga, Tatsuya Higashi. Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression. International Journal of Molecular Sciences 2020; 21(7): 2304 doi: 10.3390/ijms21072304
|
| 67 |
Jianmin Zhang, Fang Wang, Haihui Zhang, Mingbo Cao. A novel circular RNA circ_HN1/miR-628-5p/Ecto-5’-nucleotidase competing endogenous RNA network regulates gastric cancer development. Bioengineered 2021; 12(2): 9739 doi: 10.1080/21655979.2021.1989259
|
| 68 |
Xiaoyun Li, Mathias Wenes, Pedro Romero, Stanley Ching-Cheng Huang, Sarah-Maria Fendt, Ping-Chih Ho. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nature Reviews Clinical Oncology 2019; 16(7): 425 doi: 10.1038/s41571-019-0203-7
|
| 69 |
Yousef Yousefzadeh, Mohammad Sadegh Soltani-Zangbar, Ladan Kalafi, Ali Tarbiat, Sima Shahmohammadi Farid, Leili Aghebati-Maleki, Forough Parhizkar, Shahla Danaii, Simin Taghavi, Farhad Jadidi-Niaragh, Hossein Samadi Kafil, Ata Mahmoodpoor, Javad Ahmadian Heris, Mohammad Hojjat-Farsangi, Mehdi Yousefi. Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women. Molecular Biology Reports 2022; 49(11): 10183 doi: 10.1007/s11033-022-07887-z
|
| 70 |
Chun Wang, Jie Luo, Zhihang Chen, Mingliang Ye, Yinghui Hong, Jialiang Liu, Jiayan Nie, Qiu Zhao, Ying Chang. MiR-375 Impairs the Invasive Capabilities of Hepatoma Cells by Targeting HIF1α Under Hypoxia. Digestive Diseases and Sciences 2021; 66(2): 493 doi: 10.1007/s10620-020-06202-9
|
| 71 |
Zhao-wei Gao, Ke Dong, Hui-zhong Zhang. The Roles of CD73 in Cancer. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/460654
|
| 72 |
Geoffrey Alan Watson, Jeffrey Doi, Aaron Richard Hansen, Anna Spreafico. Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?. British Journal of Clinical Pharmacology 2020; 86(9): 1753 doi: 10.1111/bcp.14355
|
| 73 |
Magis Mandapathil, Mehtap Boduc, Christoph Netzer, Christian Güldner, Marion Roessler, Ute Wallicek-Dworschak, Evelyn Jahns, Boris Stuck. CD73 expression in lymph node metastases in patients with head and neck cancer. Acta Oto-Laryngologica 2018; 138(2): 180 doi: 10.1080/00016489.2017.1378436
|
| 74 |
Shuwei Guo, Fengfeng Han, Wei Zhu. CD39 – A bright target for cancer immunotherapy. Biomedicine & Pharmacotherapy 2022; 151: 113066 doi: 10.1016/j.biopha.2022.113066
|
| 75 |
Pélagie Mougola Bissiengou, Jérôme Gaston Montcho Comlan, Gabrielle Atsame Ebang, Maguette Sylla Niang, Joel Fleury Djoba Siawaya. Prostate malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8+ T lymphocytes, NK‐cells, and high frequency of CD73+ stromal cells. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1817
|
| 76 |
Lin Zhou, XiaoLan Liu, Tao Guan, HaiLing Xu, Fang Wei. CD73 Dysregulates Monocyte Anti-Tumor Activity in Multiple Myeloma. Cancer Management and Research 2023; : 729 doi: 10.2147/CMAR.S411547
|
| 77 |
Yusuke Inoue, Katsuhiro Yoshimura, Nobuya Kurabe, Tomoaki Kahyo, Akikazu Kawase, Masayuki Tanahashi, Hiroshi Ogawa, Naoki Inui, Kazuhito Funai, Kazuya Shinmura, Hiroshi Niwa, Takafumi Suda, Haruhiko Sugimura. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Oncotarget 2017; 8(5): 8738 doi: 10.18632/oncotarget.14434
|
| 78 |
Ritu Shrestha, Prashanth Prithviraj, Matthew Anaka, Kim R. Bridle, Darrell H. G. Crawford, Bijay Dhungel, Jason C. Steel, Aparna Jayachandran. Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00269
|
| 79 |
Ilaria Magagna, Nicolas Gourdin, Yann Kieffer, Monika Licaj, Rana Mhaidly, Pascale Andre, Ariane Morel, Anne Vincent-Salomon, Carine Paturel, Fatima Mechta-Grigoriou. CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer. Cancers 2021; 13(23): 5878 doi: 10.3390/cancers13235878
|
| 80 |
Zhen-Hu Ren, Cheng-Zhong Lin, Wei Cao, Rong Yang, Wei Lu, Zhe-Qi Liu, Yi-Ming Chen, Xi Yang, Zhen Tian, Li-Zhen Wang, Jiang Li, Xu Wang, Wan-Tao Chen, Tong Ji, Chen-Ping Zhang. CD73 is associated with poor prognosis in HNSCC. Oncotarget 2016; 7(38): 61690 doi: 10.18632/oncotarget.11435
|
| 81 |
Fabio Morandi, Danilo Marimpietri, Alberto L. Horenstein, Maria Valeria Corrias, Fabio Malavasi. Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells. OncoImmunology 2019; 8(5): e1574198 doi: 10.1080/2162402X.2019.1574198
|
| 82 |
Yun Xing, Zhi-qiang Ren, Rui Jin, Liang Liu, Jin-peng Pei, Ker Yu. Therapeutic efficacy and mechanism of CD73-TGFβ dual-blockade in a mouse model of triple-negative breast cancer. Acta Pharmacologica Sinica 2022; 43(9): 2410 doi: 10.1038/s41401-021-00840-z
|
| 83 |
Rocío Salsoso, Marcelo Farías, Jaime Gutiérrez, Fabián Pardo, Delia I. Chiarello, Fernando Toledo, Andrea Leiva, Alfonso Mate, Carmen M. Vázquez, Luis Sobrevia. Adenosine and preeclampsia. Molecular Aspects of Medicine 2017; 55: 126 doi: 10.1016/j.mam.2016.12.003
|
| 84 |
Isabele Cristiana Iser, Samlai Vedovatto, Fernanda Dittrich Oliveira, Liziane Raquel Beckenkamp, Guido Lenz, Márcia Rosângela Wink. The crossroads of adenosinergic pathway and epithelial-mesenchymal plasticity in cancer. Seminars in Cancer Biology 2022; 86: 202 doi: 10.1016/j.semcancer.2022.06.012
|
| 85 |
Marian S. Wettstein, Lorenz Buser, Thomas Hermanns, Filip Roudnicky, Daniel Eberli, Philipp Baumeister, Tullio Sulser, Peter Wild, Cédric Poyet. CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/785461
|
| 86 |
Yen-Hao Chen, Hung-I Lu, Chien-Ming Lo, Shau-Hsuan Li. CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma. Cancers 2021; 13(16): 3982 doi: 10.3390/cancers13163982
|
| 87 |
Zhengxin Wu, Jinshui Tan, Yifan Zhuang, Mengya Zhong, Yubo Xiong, Jingsong Ma, Yan Yang, Zhi Gao, Jiabao Zhao, Zhijian Ye, Huiwen Zhou, Yuekun Zhu, Haijie Lu, Xuehui Hong. Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02385-x
|
| 88 |
Anthony W Tolcher, Michael Gordon, Kathleen M Mahoney, Anna Seto, Marianna Zavodovskaya, Chia-Hsiang Hsueh, Shuyan Zhai, Thomas Tarnowski, Juliane M Jürgensmeier, Susanna Stinson, Ahmed A Othman, Tianling Chen, James Strauss. Phase 1 first-in-human study of dalutrafusp alfa, an anti–CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer 2023; 11(2): e005267 doi: 10.1136/jitc-2022-005267
|